Local Methylene Blue Injection for Prevention of Anastomotic Leakage and Permanent Stoma After Low Anterior Resection for Rectal Cancer

Local Methylene Blue Injection for Prevention of Anastomotic Leakage and Permanent Stoma After Low Anterior Resection for Rectal Cancer is a phase 2, interventional study registered as NCT07833319 by Peking University Cancer Hospital & Institute, with a registry enrolment figure of 26 participants, started 2025-11-25 and due to reach its primary completion in 2027-07-01. Interventions recorded: methylene blue injection. Conditions listed: Rectal Cancers. Primary outcome: Proportion of participants with successful stoma closure within 12 months after surgery. Colorectal eligibility wording from the registry: "Adults aged 18 years or older with histologically confirmed rectal adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.